Nom du produit:2-((1,3-Dioxo-1-phenylbutan-2-yl)diazenyl)-N-(quinoxalin-2-yl)benzenesulfonamide

IUPAC Name:2-[(1E)-2-(1,3-dioxo-1-phenylbutan-2-yl)diazen-1-yl]-N-(quinoxalin-2-yl)benzene-1-sulfonamide

CAS:89010-65-1
Formule moléculaire:C24H19N5O4S
Pureté:97%
Numéro de catalogue:CM222342
Poids moléculaire:473.51

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:89010-65-1
Formule moléculaire:C24H19N5O4S
Point de fusion:-
Code SMILES:O=S(C1=CC=CC=C1/N=N/C(C(C2=CC=CC=C2)=O)C(C)=O)(NC3=NC4=CC=CC=C4N=C3)=O
Densité:
Numéro de catalogue:CM222342
Poids moléculaire:473.51
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Column Infos